GlassScriptPhysician profile
Teri Lynn Duggan
NPI 1992282719
$10,893.14
in general payments reported to CMS, 2019-2025
60 companies · $1,553 in 2025
The $1,553 reported for 2025 was more than what 91% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,843 · 2022: $3,894 · 2023: $2,123 · 2024: $1,480 · 2025: $1,553.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,156.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,155.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $1,651.99 | 2022-2023 | Bulkamid, Axonics |
| Abbvie INC. | $917.59 | 2021-2025 | |
| Abbott Laboratories | $871.69 | 2023-2025 | Freestyle Libre 3 |
| Astellas Pharma US INC | $648.41 | 2021-2023 | Myrbetriq |
| Janssen Biotech, INC. | $471.79 | 2021-2023 | Erleada |
| Bayer Healthcare Pharmaceuticals INC. | $426.01 | 2021-2023 | |
| Glaxosmithkline, LLC. | $405.27 | 2021-2023 | Shingrix, Arexvy, Benlysta |
| Amgen INC. | $379.61 | 2021-2022 | |
| Endo Pharmaceuticals INC. | $343.51 | 2021-2023 | Xiaflex, Aveed |
| Neurocrine Biosciences, INC. | $297.53 | 2022-2025 | Ingrezza |
| Regeneron Healthcare Solutions, INC. | $250.00 | 2023-2024 | Dupixent |
| Medtronic, INC. | $229.76 | 2021-2024 | Linq II |
| Urovant Sciences INC | $226.67 | 2021-2022 | |
| Inspire Medical Systems, INC. | $226.09 | 2023-2024 | Inspire |
| Axsome Therapeutics, INC. | $190.10 | 2023-2025 | Auvelity |
Show all 59 companies
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Teri Duggan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.